Cargando…
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
Autores principales: | Roeker, Lindsey E., Knorr, David A., Thompson, Meghan C., Nivar, Mariely, Lebowitz, Sonia, Peters, Nicole, Deonarine, Isaac, Momotaj, Saddia, Sharan, Saumya, Chanlatte, Vanessa, Hampton, Bianca, Butala, Liana, Amato, Lindsay, Richford, Angela, Lunkenheimer, Jessica, Battiato, Kristen, Laudati, Carissa, Mato, Anthony R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118367/ https://www.ncbi.nlm.nih.gov/pubmed/33986431 http://dx.doi.org/10.1038/s41375-021-01270-w |
Ejemplares similares
-
All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
por: Thompson, Meghan C., et al.
Publicado: (2021) -
Novel-agent combination therapies in chronic lymphocytic leukemia: the law of relative contributions
por: Mato, Anthony R., et al.
Publicado: (2022) -
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2020) -
The potential of pirtobrutinib in multiple B-cell malignancies
por: Jensen, Jeffrey L., et al.
Publicado: (2022) -
A History of Targeted Therapy Development and Progress in Novel–Novel Combinations for Chronic Lymphocytic Leukemia (CLL)
por: Karr, Matthew, et al.
Publicado: (2023)